Robert W. Baird Lowers Cooper Companies (NASDAQ:COO) Price Target to $85.00

Cooper Companies (NASDAQ:COO) had its target price lowered by analysts at Robert W. Baird from $98.00 to $85.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an “outperform” rating on the medical device company’s stock. Robert W. Baird’s price target would indicate a potential upside of 37.05% from the company’s previous close.

Several other brokerages also recently commented on COO. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a report on Wednesday, May 27th. Citigroup reissued a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Rothschild & Co Redburn downgraded shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. Finally, Barclays upped their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $83.86.

Cooper Companies Stock Up 2.8%

Shares of NASDAQ:COO opened at $62.02 on Friday. Cooper Companies has a 52 week low of $58.89 and a 52 week high of $89.83. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The company’s fifty day moving average is $65.17 and its 200-day moving average is $74.57. The company has a market capitalization of $12.10 billion, a PE ratio of 30.70, a P/E/G ratio of 1.56 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company earned $0.96 EPS. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that Cooper Companies will post 4.62 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. JANA Partners Management LP acquired a new stake in shares of Cooper Companies during the 3rd quarter worth approximately $166,917,000. Alecta Tjanstepension Omsesidigt grew its position in shares of Cooper Companies by 15.8% during the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock worth $107,112,000 after buying an additional 213,500 shares during the period. DAVENPORT & Co LLC grew its position in shares of Cooper Companies by 1,359.7% during the 4th quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock worth $46,642,000 after buying an additional 528,346 shares during the period. Swiss Life Asset Management Ltd lifted its stake in shares of Cooper Companies by 63.9% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock valued at $3,387,000 after purchasing an additional 19,264 shares during the period. Finally, Fluent Financial LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at $3,517,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.